Femasys Inc. announced it will exhibit its fertility treatment and diagnostic products, including FemaSeed® Intratubal Insemination and FemVue®, at the ASRM 2026 Scientific Congress & Expo in Baltimore. This participation highlights Femasys' commitment to expanding fertility care options, particularly through collaborations with OB/GYNs and reproductive endocrinologists. The company is also advancing its non-surgical permanent birth control product, FemBloc®, toward FDA approval. This event provides a platform to promote Femasys' portfolio and discuss integration into existing fertility care workflows.
Femasys' participation in the ASRM 2026 Scientific Congress & Expo is noted with Pluang's Health-sector market data as of Oct 08, 2026 19:42 WIB: out of 128 priced US Health stocks, 34 rose and 88 fell. Among notable movers, CRSP traded at USD 51.26 with a 1-day change of -2.08%, ABEO at USD 5.18 rose 1.97%, and NVAX at USD 11.00 declined 1.96%. The highest buy-side interest was for ABEO at 100% buy orders.
CIQ has released Fuzzball 4.3, a platform that enables enterprises to deploy validated open-weight AI models and agents on their existing GPU infrastructure with a single command. This update simplifies operationalizing AI by automatically connecting...
As of September 30, 2026, Societe Generale's share capital consists of 739,264,232 shares with a total of 821,169,560 voting rights. The bank highlights its strong global presence with 110,000 employees serving 27 million clients across 58 countries....
Weyerhaeuser's stock recently dropped to a new 52-week low of $18.31, trading around $18.51, reflecting market pressure. Analysts have mixed views: Seaport Global lowered its price target to $30, Raymond James upgraded to "strong buy" with the same t...
Canadian Utilities and Emera have agreed to merge as equals, creating a larger utility and energy infrastructure company. RBC Capital maintains a 'Sector Perform' rating on Canadian Utilities, indicating expected performance in line with the sector. ...
Domino's Pizza is set to report its Q3 earnings on October 13, 2026, with analysts forecasting earnings per share between $4.33 and $4.36 and revenue around $1.17 billion, a 1.6% increase year-over-year. Investors will watch closely how promotional d...
